Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News (Page 4)
Related terms: Metastatic Breast Cancer
Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
THURSDAY, Oct. 17, 2024 – Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI), according to a study...
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
WEDNESDAY, Oct. 16, 2024 – The U.S. Food and Drug Administration approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with...
New Hope Against Breast Cancers That Spread to the Brain
TUESDAY, Oct. 8, 2024 – A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical...
Breast Cancer Treatments Might Speed Aging, Study Finds
TUESDAY, Oct. 8, 2024 – Any form of breast cancer treatment appears to speed the aging of the recipient's cells, a new study finds. “For the first time, we're showing that the [aging] signals we o...
AI May Identify Women at Risk for Future Breast Cancer
TUESDAY, Oct. 8, 2024 – Artificial intelligence (AI) scores may be able to estimate the risk for future breast cancer and lead to earlier diagnosis, according to a study published online Oct. 3...
U.S. Breast Cancer Deaths Keep Declining, Though Disparities Remain
TUESDAY, Oct. 1, 2024 – While women overall are less likely to die of breast cancer now, some alarming disparities remain, a new American Cancer Society (ACS) analysis warns. Death rates for...
Upward Trends in Breast Cancer Incidence Continuing Among Women
TUESDAY, Oct. 1, 2024 – Upward trends in breast cancer incidence among women have continued, according to a study published online Oct. 1 in CA: A Cancer Journal for Clinicians. Angela N. Giaquinto,...
Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
FRIDAY, Sept. 27, 2024 – An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept....
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
TUESDAY, Sept. 17, 2024 – For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC),...
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 – Black women have a higher risk of dying from any type of breast cancer than white women, a new review finds. Overall, the increased survival risk for Black women ranges...
FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 – Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded...
FDA Approves Truqap (capivasertib) plus Faslodex for Patients with Advanced HR-Positive Breast Cancer
17 November 2023 – AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, ...
FDA Approves Margenza (margetuximab-cmkb) for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
ROCKVILLE, MD, Dec. 16, 2020 (GLOBE NEWSWIRE) – MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based ...
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer
South San Francisco, CA – June 29, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo,...
FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer
Morris Plains, N.J., April 22, 2020 — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today anno...
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Herceptin, Arimidex, Femara, trastuzumab, tamoxifen, Ibrance, docetaxel